Osteoblast-derived exosomes promote osteogenic differentiation of osteosarcoma cells via URG4/Wnt signaling pathway
Bone · 2024-01 · 178 · 116933
DOI: 10.1016/j.bone.2023.116933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2024-01. Verfasst von Yuanxi Leng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedics and Traumatology Department VI, Affiliated Hongdu Traditional Chinese Medicine Hospital of Jiangxi University of Traditional Chinese Medi…. Hauptthemen laut MEDLINE: Exosomes, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteosarcoma is a primary malignant bone tumor. Although surgery and chemotherapy are the main treatment methods, the overall curative effect remains unsatisfactory. Therefore, there is an urgent need to develop new therapeutic options for osteosarcoma. In this study, the effect and molecular mechanism of osteoblast-derived exosomes on the treatment of osteosarcoma were evaluated. Human primary osteoblasts were cultured to observe the effects of osteoblast-derived exosomes on the osteogenic differentiation of osteosarcoma cells both in vitro and in vivo. Alizarin red staining and alkaline phosphatase detection were used to evaluate the degree of osteogenic differentiation, and immunofluorescence and Western blotting were used to detect protein expression. The results showed that osteoblast-derived exosomes effectively inhibited the proliferation of osteosarcoma cells and promoted their mineralization in vitro. The exosomes also significantly inhibited tumor growth and promoted tumor tissue mineralization in vivo. Osteoblast-derived exosomes upregulated the expression of bone sialoprotein, osteonectin, osteopontin, runt-related transcription factor 2, and Wnt inhibitory factor 1, downregulated the expression of cyclin D1, and suppressed the nuclear accumulation of β-catenin and promoted its phosphorylation in vitro and in vivo. However, these effects were significantly reversed by upregulated gene (URG) 4 overexpression. These findings suggest that osteoblast-derived exosomes could activate the osteogenic differentiation process in osteosarcoma cells and promote their differentiation by targeting the URG4/Wnt signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Orthopedics and Traumatology Department VI, Affiliated Hongdu Traditional Chinese Medicine Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi Province 330008, PR China.
- Department of Orthopaedics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi Province 330006, PR China.
- Department of Orthopaedics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi Province 330006, PR China. Electronic address: nclyy2005265@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Leng, Y., Li, J., Long, Z., Li, C., Zhang, L., Huang, Z., Xi, J., & Liu, Y. (2024). Osteoblast-derived exosomes promote osteogenic differentiation of osteosarcoma cells via URG4/Wnt signaling pathway. Bone, 178, 116933. https://doi.org/10.1016/j.bone.2023.116933
Vancouver
Leng Y, Li J, Long Z, Li C, Zhang L, Huang Z, et al. Osteoblast-derived exosomes promote osteogenic differentiation of osteosarcoma cells via URG4/Wnt signaling pathway. Bone. 2024;178:116933. doi:10.1016/j.bone.2023.116933
BibTeX
@article{Leng2024,
author = {Leng, Yuanxi and Li, Jingtang and Long, Zhisheng and Li, Chen and Zhang, Liang and Huang, Zutai and Xi, Jinfeng and Liu, Yayun},
title = {Osteoblast-derived exosomes promote osteogenic differentiation of osteosarcoma cells via URG4/Wnt signaling pathway},
journal = {Bone},
year = {2024},
volume = {178},
pages = {116933},
doi = {10.1016/j.bone.2023.116933}
}
EUVIMED